Product Recalls in Kentucky

Product recalls affecting Kentucky — including food, drugs, consumer products, medical devices, and vehicles distributed to Kentucky. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,609 recalls have been distributed to Kentucky in the last 12 months.

51,386 total recalls
2,609 in last 12 months

Showing 1334113360 of 13,398 recalls

DrugApril 30, 2012· Apotex Inc.

Recalled Item: Dorzolamide HCI/Timolol Maleate Ophthalmic Solution 22.3mg/6.8mg per mL...

The Issue: Presence of Particulate Matter: Lots identified in this recall notification...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 24, 2012· Teva Pharmaceuticals USA, Inc.

Recalled Item: CABERGOLINE Tablets Recalled by Teva Pharmaceuticals USA, Inc. Due to...

The Issue: Impurities/Degradation Products: This lot of product will not meet the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 24, 2012· Luitpold Pharmaceuticals, Inc.

Recalled Item: Epinephrine Injection Recalled by Luitpold Pharmaceuticals, Inc. Due to...

The Issue: Presence of Particulate Matter

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 23, 2012· Teva Pharmaceuticals USA, Inc.

Recalled Item: Jolessa (levonorgestrel/ethinyl estradiol tablets Recalled by Teva...

The Issue: Contraceptive Tablets Out of Sequence: This recall has been initiated due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 21, 2012· XRock Industries, LLC

Recalled Item: X-ROCK For Men Recalled by XRock Industries, LLC Due to Marketed Without an...

The Issue: Marketed Without an Approved NDA/ANDA: product tested positive for PDE-5...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 17, 2012· Hospira Inc.

Recalled Item: Morphine Sulfate Injection Recalled by Hospira Inc. Due to Superpotent;...

The Issue: Superpotent; Cartridges labeled to contain 1 mL found to contain 2.2 mL

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 17, 2012· Watson Laboratories Inc

Recalled Item: Loxapine Capsules USP Recalled by Watson Laboratories Inc Due to Labeling:...

The Issue: Labeling: Incorrect or Missing Package Insert: An outdated version of a...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 17, 2012· Watson Laboratories Inc

Recalled Item: Loxapine Capsules USP Recalled by Watson Laboratories Inc Due to Labeling:...

The Issue: Labeling: Incorrect or Missing Package Insert: An outdated version of a...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 17, 2012· Watson Laboratories Inc

Recalled Item: Loxapine Capsules USP Recalled by Watson Laboratories Inc Due to Labeling:...

The Issue: Labeling: Incorrect or Missing Package Insert: An outdated version of a...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 17, 2012· Watson Laboratories Inc

Recalled Item: Loxapine Capsules USP Recalled by Watson Laboratories Inc Due to Labeling:...

The Issue: Labeling: Incorrect or Missing Package Insert: An outdated version of a...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 17, 2012· Watson Laboratories Inc

Recalled Item: Loxitane Capsules Recalled by Watson Laboratories Inc Due to Labeling:...

The Issue: Labeling: Incorrect or Missing Package Insert: An outdated version of a...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 16, 2012· Bracco Diagnostics Inc

Recalled Item: Bracco Diagnostics multihance (gadobenate dimeglumine) injection Recalled by...

The Issue: Short Fill: The product is being recalled due to a potential underfill of...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 16, 2012· Bracco Diagnostics Inc

Recalled Item: Multihance Multipack (gadobenate dimeglumine) injection Recalled by Bracco...

The Issue: Lack of Assurance of Sterility; Product recalled due to displacement of the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 11, 2012· Hospira, Inc.

Recalled Item: Propofol Injectable Emulsion Recalled by Hospira, Inc. Due to Presence of...

The Issue: Presence of Particulate Matter: A single visible particulate was observed in...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 9, 2012· Dr. Reddy's Laboratories, Inc.

Recalled Item: Dr. Reddy's Ciprofloxacin Tablets Recalled by Dr. Reddy's Laboratories, Inc....

The Issue: Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 9, 2012· Dr. Reddy's Laboratories, Inc.

Recalled Item: Dr. Reddy's Amlodipine Besylate and Benazepril Hydrochloride 5 mg*/20 mg...

The Issue: Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 5, 2012· Apotex Corp.

Recalled Item: Meloxicam Tablets Recalled by Apotex Corp. Due to Tablet Thickness: Recall...

The Issue: Tablet Thickness: Recall was initiated due to the presence of one slightly...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 5, 2012· Hospira, Inc.

Recalled Item: Magnesium Sulfate in Water for Injection Recalled by Hospira, Inc. Due to...

The Issue: Superpotent (Single Ingredient) Drug: Above specification assay results for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 2, 2012· Teva Pharmaceuticals USA, Inc.

Recalled Item: Mefloquine HCL Tablets Recalled by Teva Pharmaceuticals USA, Inc. Due to...

The Issue: Tablet Thickness: Product is being recalled due to the potential of being...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 29, 2012· McKesson Packaging Services

Recalled Item: buPROPion Hydrochloride Extended-Release Tablets (XL) Recalled by McKesson...

The Issue: Failed USP Dissolution Test Requirements: Possible out-of-specification...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund